{"category":{"kind":"industry","slug":"drug-delivery","name":"Drug Delivery","tagline":null,"description":null,"synonyms":[],"target_queries":[],"added_via":"pr","added_at":"2026-09-03T06:11:22.969Z","updated_at":"2026-09-03T06:11:22.969Z","example":false,"profile_url":"/industries/drug-delivery","is_stub":true,"member_count":10,"member_counts":{"company":10}},"members":[{"listing_type":"company","name":"ArrayPatch","slug":"arraypatch","tagline":"Polymer-free dissolving microneedle patches for drug delivery","description":"ArrayPatch is a Cork, Ireland biotechnology company developing DerMap, a dissolving microneedle patch made entirely from the drug itself for pain-free intradermal delivery. Its pipeline includes GLP-DerMap for obesity and type 2 diabetes medicines, Skin Cancer DerMap, and ITZ-DerMap for onychomycosis. In November 2026 it completed an oversubscribed €3.2 million seed financing to advance next-generation microneedle therapeutics.","url":"https://array-patch.com/","is_stealth":false,"normalized_domain":"array-patch.com","normalized_url_key":"array-patch.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://array-patch.com/wp-content/uploads/2024/05/Heading2-ezgif.com-png-to-webp-converter.webp","links":[{"label":"€3.2M seed (GlobeNewswire, Nov 2026)","url":"https://www.globenewswire.com/news-release/2026/11/05/3396093/0/en/arraypatch-completes-oversubscribed-3-2-million-seed-financing-to-advance-next-generation-microneedle-therapeutics.html","platform":"news"}],"entry_points":[{"kind":"homepage","url":"https://array-patch.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://array-patch.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":{"logo_asset_id":"4ee82e79-7fdf-4f77-995a-90d4f2dc419e"},"categories":["Biotech","Drug Delivery","Digital Health","Therapeutics"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":"https://www.linkedin.com/company/arraypatch-ltd","contact_email":null,"added_at":"2026-11-06T04:26:34.163Z","added_via":"web","geo":null,"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-11-06T04:26:56.055Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"biotech","name":"BioTech","note":null,"profile_url":"/industries/biotech"},{"kind":"industry","slug":"digital-health","name":"Digital Health","note":null,"profile_url":"/industries/digital-health"},{"kind":"industry","slug":"drug-delivery","name":"Drug Delivery","note":null,"profile_url":"/industries/drug-delivery"},{"kind":"industry","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/industries/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-11-06T04:26:34.163Z","updated_at":"2026-11-06T04:26:34.163Z"}},{"listing_type":"company","name":"EpiQuil","slug":"epiquil","tagline":"Dissolving microneedle patches for controlled transdermal drug delivery","description":"EpiQuil is an Australian medtech company developing an investigational dissolving microneedle patch platform for controlled transdermal delivery of lipophilic active ingredients. It is one of 16 startups in UNSW Founders' 2026 10x Accelerator cohort, which each received a A$100,000 pre-seed investment.","url":"https://www.epiquil.com/","is_stealth":false,"normalized_domain":"epiquil.com","normalized_url_key":"epiquil.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://static1.squarespace.com/static/6936986b5c13f155588b70ca/t/697dcfd4bea6147b8135666c/1769852884697/Favicon.png?format=1500w","links":[{"label":"Startup Daily: UNSW 10x Accelerator first cheques to 16 startups","url":"https://www.startupdaily.net/advice/investing/before-vcs-a-university-writes-the-first-cheque/","platform":"other"}],"entry_points":[{"kind":"homepage","url":"https://www.epiquil.com/","audience":"human","primary":true,"listed_by":"community","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.epiquil.com/","audience":"human","primary":true,"listed_by":"community","on_listing_domain":true},"agent":null},"founders":[],"media":{"logo_asset_id":"1333950d-90c1-4ff7-b895-168415efa182"},"categories":["MedTech","Drug Delivery","Healthcare"],"stage":"pre-seed","founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":"https://www.linkedin.com/company/epiquil/","contact_email":null,"added_at":"2026-10-18T19:27:58.197Z","added_via":"web","geo":null,"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-10-18T19:27:58.197Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"drug-delivery","name":"Drug Delivery","note":null,"profile_url":"/industries/drug-delivery"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"medtech","name":"MedTech","note":null,"profile_url":"/industries/medtech"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-10-18T19:27:58.197Z","updated_at":"2026-10-18T19:27:58.197Z"}},{"listing_type":"company","name":"Undecimal Bio","slug":"undecimal-bio","tagline":"AI-driven siRNA delivery to take RNA therapeutics beyond the liver","description":"Undecimal Bio pairs large-scale combinatorial chemistry with transformer-based AI to discover small-molecule conjugates that deliver siRNA into tissues beyond the liver. Its screens score productive intracellular delivery and feed models that map structure-activity relationships across tissues; first programs target renovascular disease in the kidney and vascular system. Co-founders include CEO Prof. Yaniv Erlich and COO Shaul Ilan. In October 2026 the company launched publicly with $18 million in financing reported by Endpoints News.","url":"https://undecimalbio.com/","is_stealth":false,"normalized_domain":"undecimalbio.com","normalized_url_key":"undecimalbio.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://cdn.prod.website-files.com/6ac74ac55496dc650fd7c337/6acb50f4fd546b4418352f54_UndecimalBio%20-%20Favicon%20%5Bon%20light%5D.png","links":[{"label":"LinkedIn","url":"https://www.linkedin.com/company/undecimal-bio","platform":"linkedin"},{"label":"Endpoints News launch coverage","url":"https://endpoints.news/undecimal-bio-launches-with-18m-to-advance-sirna-beyond-liver-disease/"}],"entry_points":[{"kind":"homepage","url":"https://undecimalbio.com/","audience":"any","primary":true,"listed_by":"community","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://undecimalbio.com/","audience":"any","primary":true,"listed_by":"community","on_listing_domain":true},"agent":{"kind":"homepage","url":"https://undecimalbio.com/","audience":"any","primary":true,"listed_by":"community","on_listing_domain":true}},"founders":[{"name":"Yaniv Erlich","role":"Co-Founder and CEO","person_slug":"yaniv-erlich-2g7zscgw6u7ss","bio":null,"location":null,"links":[]},{"name":"Shaul Ilan","role":"Co-Founder and COO","person_slug":"shaul-ilan-3ivokcu3773t9","bio":null,"location":null,"links":[]}],"media":{"logo_asset_id":"1848c912-f6d4-4157-9226-c80a800dbcf3"},"categories":["Biotech","AI","Drug Delivery","Therapeutics"],"stage":null,"founded_year":null,"location":"Cambridge, UK","pricing":null,"twitter":null,"github":null,"linkedin":"https://www.linkedin.com/company/undecimal-bio","contact_email":null,"added_at":"2026-10-13T01:24:44.014Z","added_via":"web","geo":null,"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-10-13T01:24:44.014Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"ai","name":"AI","note":null,"profile_url":"/industries/ai"},{"kind":"industry","slug":"biotech","name":"BioTech","note":null,"profile_url":"/industries/biotech"},{"kind":"industry","slug":"drug-delivery","name":"Drug Delivery","note":null,"profile_url":"/industries/drug-delivery"},{"kind":"industry","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/industries/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-10-13T01:24:44.014Z","updated_at":"2026-10-13T01:24:44.014Z"}},{"listing_type":"company","name":"Cerentry Bio","slug":"cerentry-bio","tagline":"Brain shuttle for systemic drug delivery across brain barriers","description":"Cerentry Bio is a Denmark-based biotech spin-out developing a proprietary brain shuttle to transport systemically administered therapeutics across the brain's protective barriers. Rather than focusing only on the blood-brain barrier, Cerentry develops drug conjugates for transport across the blood-cerebrospinal fluid barrier (BCSFB) to improve access to the central nervous system. The company is based on collaborative work between professors at the Technical University of Denmark and the University of Copenhagen and participates in the BioInnovation Institute / Lundbeck Foundation Venture Lab program.","url":"https://www.cerentry.com/","is_stealth":false,"normalized_domain":"cerentry.com","normalized_url_key":"cerentry.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://images.squarespace-cdn.com/content/v1/69bbe2d7a07ba25e9ceacc40/1a4b8178-d00b-4e16-bf53-21db5f9d6a63/Logo+Cerentry.png?format=1500w","links":[{"label":"LinkedIn","url":"https://www.linkedin.com/company/cerentry","platform":"linkedin"}],"entry_points":[{"kind":"homepage","url":"https://www.cerentry.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.cerentry.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[{"name":"Maria Deslauriers","role":"CEO / Co-Founder","person_slug":"maria-deslauriers-34v3dk6xi56vb","bio":null,"location":null,"links":[]},{"name":"Katrine Qvortrup","role":"CSO / Co-Founder","person_slug":"katrine-qvortrup-2wkhvhmxd89ul","bio":null,"location":null,"links":[]},{"name":"Mette Rosenkilde","role":"Co-Founder","person_slug":"mette-rosenkilde-1g3rq8g1v0bb1","bio":null,"location":null,"links":[]}],"media":{"logo_asset_id":"8e643254-e3cf-466f-92ee-26cc51858f55"},"categories":["Biotech","Healthcare","Drug Delivery","B2B"],"stage":null,"founded_year":null,"location":"Denmark","pricing":null,"twitter":null,"github":null,"linkedin":"https://www.linkedin.com/company/cerentry","contact_email":null,"added_at":"2026-09-16T08:10:36.446Z","added_via":"web","geo":null,"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-16T08:10:36.446Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"b2b","name":"B2B","note":null,"profile_url":"/industries/b2b"},{"kind":"industry","slug":"biotech","name":"BioTech","note":null,"profile_url":"/industries/biotech"},{"kind":"industry","slug":"drug-delivery","name":"Drug Delivery","note":null,"profile_url":"/industries/drug-delivery"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-16T08:10:36.446Z","updated_at":"2026-09-16T08:10:36.446Z"}},{"listing_type":"company","name":"Convexia","slug":"convexia","tagline":"The world's first AI-maximalist pharma company","description":"An AI-maximalist pharma platform. We use agents to buy drugs, run clinical trials, and sell for a profit. 10x faster and 20x leaner than incumbents.\n\nSourcing Agent: Mines public/private databases and unstructured global data to surface overlooked preclinical candidates.\nScientific Agent: Runs comp bio models (ESM-3, RFdiffusion, Boltz-2, AlphaFold) to assess safety and efficacy in silico.\nCommercial Agent: Analyzes FDA incentives, pricing dynamics, TAM, competitive landscape, and payer alignment.\nClinical Agent: Runs digital twin simulations, evaluates CRO/CMC risk, and builds trial plans to Phase 1.\nPoS Agent: Evaluates the most critical factors that impact the likelihood of clinical trial success. \n\nBuilt by 2 Stanford CS students who have built 3 startups together before.\n\nConvexia is a Y Combinator company (Summer 2025). YC-listed status: Active.","url":"https://www.convexia.bio/","is_stealth":false,"normalized_domain":"convexia.bio","normalized_url_key":"convexia.bio","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/c68bf871c0fe363c6048343df283d9282ab990f4.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/convexia","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://www.convexia.bio/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.convexia.bio/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Drug Discovery and Delivery","AI-powered Drug Discovery","Biotech","Drug Delivery"],"stage":null,"founded_year":null,"location":"San Francisco, CA, USA","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T08:12:15.441Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Summer 2025","AI-powered Drug Discovery","Biotech","Drug Delivery"],"one_liner_for_search":"Convexia — The world's first AI-maximalist pharma company (Y Combinator Summer 2025)","canonical_facts":["Y Combinator batch: Summer 2025","YC company status: Active","Team size (per YC directory): 4","YC industry: Healthcare","YC subindustry: Healthcare / Drug Discovery and Delivery","Regions (per YC): United States of America, America / Canada"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T08:12:15.441Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"ai-powered-drug-discovery","name":"AI-powered Drug Discovery","note":null,"profile_url":"/industries/ai-powered-drug-discovery"},{"kind":"industry","slug":"biotech","name":"BioTech","note":null,"profile_url":"/industries/biotech"},{"kind":"industry","slug":"drug-delivery","name":"Drug Delivery","note":null,"profile_url":"/industries/drug-delivery"},{"kind":"industry","slug":"drug-discovery-and-delivery","name":"Drug Discovery and Delivery","note":null,"profile_url":"/industries/drug-discovery-and-delivery"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T08:12:15.441Z","updated_at":"2026-09-03T08:12:15.441Z"}},{"listing_type":"company","name":"Nanograb","slug":"nanograb","tagline":"Deliver genes to any cell with AI","description":"Nanograb is a computational drug discovery company that uses AI to create novel targeted non-viral gene therapy vectors. Our platform designs unique combinations of small peptide binders attached to nanoparticles to safely deliver genetic medicines to specific cells and tissues in the body at scale.\n\nNanograb is a Y Combinator company (Summer 2023). YC-listed status: Active.","url":"https://nanograb.com/","is_stealth":false,"normalized_domain":"nanograb.com","normalized_url_key":"nanograb.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/9ae1f1866a70286591b56aa5fd2f81bdf18af255.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/nanograb","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://nanograb.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://nanograb.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Drug Discovery and Delivery","AI-powered Drug Discovery","Nanomedicine","Biotech","Drug Delivery","Therapeutics"],"stage":null,"founded_year":null,"location":"London, England, United Kingdom","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T07:35:07.337Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Summer 2023","AI-powered Drug Discovery","Nanomedicine","Biotech","Drug Delivery","Therapeutics"],"one_liner_for_search":"Nanograb — Deliver genes to any cell with AI (Y Combinator Summer 2023)","canonical_facts":["Y Combinator batch: Summer 2023","YC company status: Active","Team size (per YC directory): 5","YC industry: Healthcare","YC subindustry: Healthcare / Drug Discovery and Delivery","Regions (per YC): United Kingdom, Europe"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T07:35:07.337Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"ai-powered-drug-discovery","name":"AI-powered Drug Discovery","note":null,"profile_url":"/industries/ai-powered-drug-discovery"},{"kind":"industry","slug":"biotech","name":"BioTech","note":null,"profile_url":"/industries/biotech"},{"kind":"industry","slug":"drug-delivery","name":"Drug Delivery","note":null,"profile_url":"/industries/drug-delivery"},{"kind":"industry","slug":"drug-discovery-and-delivery","name":"Drug Discovery and Delivery","note":null,"profile_url":"/industries/drug-discovery-and-delivery"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"nanomedicine","name":"Nanomedicine","note":null,"profile_url":"/industries/nanomedicine"},{"kind":"industry","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/industries/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T07:35:07.337Z","updated_at":"2026-09-03T07:35:07.337Z"}},{"listing_type":"company","name":"Keylika","slug":"keylika","tagline":"Redefining the Standard of Care for Iron Deficiency Anemia","description":"Keylika is an early stage biopharma startup developing metal-based drugs using a platform synthesis technology to treat unmet medical needs. We then administer these drugs using proven delivery technologies to effect the best clinical outcomes. \n\nOur first product is a small molecule iron drug (new molecular entity) delivered by a wearable skin patch to treat Iron Deficiency Anemia (IDA), with significantly higher safety, efficacy and tolerability over existing treatments. This is poised to be a best-in-class, potentially breakthrough therapy for treating iron deficiency without any GI side-effects (eg. nausea, constipation, diarrhea, etc.) typically associated with oral iron supplements, and without the risks, costs and side-effects associated with IV iron infusions. When approved, Keylika’s proprietary transdermal iron will be the world's first prescription iron patch. Iron deficiency is a hugely understated problem affecting about 1.6 billion people worldwide and more than 30 million in the US alone, translating to a $17B US market.\n\nKeylika is a Y Combinator company (Summer 2022). YC-listed status: Active.","url":"https://www.keylika.com/","is_stealth":false,"normalized_domain":"keylika.com","normalized_url_key":"keylika.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/bd12fc4dc5d053441f31a9c528579e0d16f3449e.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/keylika","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://www.keylika.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.keylika.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Therapeutics","AI-powered Drug Discovery","Medical Devices","Drug Delivery","Nanotechnology"],"stage":null,"founded_year":null,"location":"San Francisco, CA, USA; Walnut Creek, CA, USA","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T07:00:15.920Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Summer 2022","AI-powered Drug Discovery","Medical Devices","Drug Delivery","Nanotechnology","Therapeutics"],"one_liner_for_search":"Keylika — Redefining the Standard of Care for Iron Deficiency Anemia (Y Combinator Summer 2022)","canonical_facts":["Y Combinator batch: Summer 2022","YC company status: Active","Team size (per YC directory): 1","YC industry: Healthcare","YC subindustry: Healthcare / Therapeutics","Regions (per YC): United States of America, America / Canada, Remote, Partly Remote"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T07:00:15.920Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"ai-powered-drug-discovery","name":"AI-powered Drug Discovery","note":null,"profile_url":"/industries/ai-powered-drug-discovery"},{"kind":"industry","slug":"drug-delivery","name":"Drug Delivery","note":null,"profile_url":"/industries/drug-delivery"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"medical-devices","name":"Medical Devices","note":null,"profile_url":"/industries/medical-devices"},{"kind":"industry","slug":"nanotechnology","name":"Nanotechnology","note":null,"profile_url":"/industries/nanotechnology"},{"kind":"industry","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/industries/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T07:00:15.920Z","updated_at":"2026-09-03T07:00:15.920Z"}},{"listing_type":"company","name":"Intact Therapeutics","slug":"intact-therapeutics","tagline":"Smart gels for local drug delivery to the gut","description":"Intatct is developing an advanced materials platform to improve the way drugs are delivered and absorbed in the digestive tract. Our vision is to improve the treatment of a wide range of gastrointestinal disorders that are currently underserved.\n\nIntact Therapeutics is a Y Combinator company (Winter 2019). YC-listed status: Active.","url":"https://intacttherapeutics.com/","is_stealth":false,"normalized_domain":"intacttherapeutics.com","normalized_url_key":"intacttherapeutics.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/3cd29a4a99693702d0e100b9a7d5fbcf89df7edc.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/intact-therapeutics","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://intacttherapeutics.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://intacttherapeutics.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Therapeutics","Drug Delivery"],"stage":null,"founded_year":null,"location":"San Francisco, CA, USA; Los Altos, CA, USA","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T06:20:10.103Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Winter 2019","Drug Delivery","Therapeutics"],"one_liner_for_search":"Intact Therapeutics — Smart gels for local drug delivery to the gut (Y Combinator Winter 2019)","canonical_facts":["Y Combinator batch: Winter 2019","YC company status: Active","Team size (per YC directory): 4","YC industry: Healthcare","YC subindustry: Healthcare / Therapeutics","Regions (per YC): United States of America, America / Canada, Remote, Partly Remote"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T06:20:10.103Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"drug-delivery","name":"Drug Delivery","note":null,"profile_url":"/industries/drug-delivery"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/industries/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T06:20:10.103Z","updated_at":"2026-09-03T06:20:10.103Z"}},{"listing_type":"company","name":"Avro Life Science","slug":"avro-life-science","tagline":"Skin patches for generic drug delivery.","description":"Skin patches for generic drug delivery.\n\nAvro Life Science is a Y Combinator company (Winter 2018). YC-listed status: Active.","url":"https://www.avrolifesci.com/","is_stealth":false,"normalized_domain":"avrolifesci.com","normalized_url_key":"avrolifesci.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/5ac9275384f9ff51e1062f157268e402e8ef1354.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/avro-life-science","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://www.avrolifesci.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.avrolifesci.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Drug Discovery and Delivery","Biotech","Drug Delivery"],"stage":null,"founded_year":null,"location":"Waterloo, ON, Canada","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T06:11:30.364Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Winter 2018","Biotech","Drug Delivery"],"one_liner_for_search":"Avro Life Science — Skin patches for generic drug delivery. (Y Combinator Winter 2018)","canonical_facts":["Y Combinator batch: Winter 2018","YC company status: Active","Team size (per YC directory): 8","YC industry: Healthcare","YC subindustry: Healthcare / Drug Discovery and Delivery","Regions (per YC): Canada, America / Canada"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T06:11:30.364Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"biotech","name":"BioTech","note":null,"profile_url":"/industries/biotech"},{"kind":"industry","slug":"drug-delivery","name":"Drug Delivery","note":null,"profile_url":"/industries/drug-delivery"},{"kind":"industry","slug":"drug-discovery-and-delivery","name":"Drug Discovery and Delivery","note":null,"profile_url":"/industries/drug-discovery-and-delivery"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T06:11:30.364Z","updated_at":"2026-09-03T06:11:30.364Z"}},{"listing_type":"company","name":"Sixfold Bioscience","slug":"sixfold-bioscience","tagline":"Delivering RNA therapies.","description":"Sixfold is focused on the commercialisation of its patented drug delivery systems for RNA therapeutics such as siRNAs for gene silencing and mRNAs for gene expression.\n\nSixfold Bioscience is a Y Combinator company (Winter 2018). YC-listed status: Active.","url":"https://www.sixfold.bio/","is_stealth":false,"normalized_domain":"sixfold.bio","normalized_url_key":"sixfold.bio","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/b0f895aea5a3becf96dd016714d9e8aa78189e1b.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/sixfold-bioscience","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://www.sixfold.bio/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.sixfold.bio/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Drug Discovery and Delivery","Gene Therapy","Nanomedicine","Drug Delivery"],"stage":null,"founded_year":null,"location":"London, England, United Kingdom","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T06:11:22.969Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Winter 2018","Gene Therapy","Nanomedicine","Drug Delivery"],"one_liner_for_search":"Sixfold Bioscience — Delivering RNA therapies. (Y Combinator Winter 2018)","canonical_facts":["Y Combinator batch: Winter 2018","YC company status: Active","Team size (per YC directory): 27","YC industry: Healthcare","YC subindustry: Healthcare / Drug Discovery and Delivery","Former names: Sixfold Bioscience","Regions (per YC): United Kingdom, Europe"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T06:11:22.969Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"drug-delivery","name":"Drug Delivery","note":null,"profile_url":"/industries/drug-delivery"},{"kind":"industry","slug":"drug-discovery-and-delivery","name":"Drug Discovery and Delivery","note":null,"profile_url":"/industries/drug-discovery-and-delivery"},{"kind":"industry","slug":"gene-therapy","name":"Gene Therapy","note":null,"profile_url":"/industries/gene-therapy"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"nanomedicine","name":"Nanomedicine","note":null,"profile_url":"/industries/nanomedicine"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T06:11:22.969Z","updated_at":"2026-09-03T06:11:22.969Z"}}],"total":10,"limit":50,"offset":0}